Is it time to drug test your chronic pain patient?

Journal of Family Practice

Volumn 59, Issue 11, 2010, Pages 628-633

  McBane, Sarah ^a   Weigle, Nancy ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMPHETAMINE; CODEINE; HYDROCODONE; OXYCODONE PLUS PARACETAMOL;

ADULT; ARTICLE; BACKACHE; CASE REPORT; CHRONIC PAIN; COCAINE DEPENDENCE; DIABETES MELLITUS; DRUG ABUSE; DRUG SCREENING; DRUG URINE LEVEL; DRUG USE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; LUNG NODULE; MEDICAL PRACTICE; PRESCRIPTION; THORAX RADIOGRAPHY; URINALYSIS;

ADULT; ANALGESICS, OPIOID; CHRONIC DISEASE; FEMALE; HUMANS; HYDROCODONE; MALE; MIDDLE AGED; OXYCODONE; PAIN;

EID: 78649382315     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Health Care Issues. Joint Commission on Accreditation of Health Care Organizations. Available at: http://www.jointeommission.org/. Accessed March 5, 2010.
2. Standards, Laws, and Regulations Addressing Pain Medications and Medical Practice: Report 6 of the Council on Science and Public Health. American Medical Association. June 2007. Available at: http://www.ama-assn.org/ama/pub/ physician-resources/medical-science/council-science-public-health.shtml. Accessed July 16, 2009.
3. US Department of Justice Drug Enforcement Administration Office of Diversion Control. Available at: http://www.deadiversion.usdoj.gov/. Accessed March 5, 2010.
4. Federation of State Medical Boards. Model Policy for the Use of Controlled Substances for the Treatment of Pain. May 2004. Available at: http://www.fsmb.org/pdf/2004-grpol-Controlled-Substances.pdf. Accessed March 5, 2010.
5. Centers for Disease Control and Prevention. Prescription Drug Overdose: State Health Agencies Respond. Available at: http://www.cdc.gov/ HomeandRecreationalSafety/pubs/RXReport-web-a.pdf. Accessed May 15, 2010.
6. Drug Enforcement Agency Office of Diversion Control NFLIS Special Report: Controlled Substance Prescription Drugs 2001-2005. November 2006. Available at: http://www.deadiversion.usdoj.gov/nflis/2006rx-drugs-report.pdf. Accessed May 15, 2010.
7. Department of Health and Human Services Office of Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: national findings. Available at: http://www.oas.samhsa.gov/ nsduh/2k7nsduh/2k7Results.pdf. Accessed May 7, 2010.
8. Reisfield G, Salazar E, Bertholf R. Rational use and interpretation of urine drug testing in chronic opioid therapy. Ann Clin Lab Sci. 2007;37:301-314. (Pubitemid 350105930)
9. Clinical Pharmacology [online]. Tampa, FL: Gold Standard Inc; 2010. Available at: http://cp.gsm.com. Accessed March 5, 2010.
10. Drug abuse urine tests: false-positive results. Pharmacist's Letter/Prescriber's Letter. 2005;21:210314.
11. Reisfield GM, Webb FJ, Bertholf RL, et al. Family physicians' proficiency in urine drug test interpretation. J Opioid Manag. 2007;3:333-337.
12. Adams N, Plane M, Fleming M, et al. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001;22:791-796.
13. Gourlay D, Caplan Y, Heit H. Urine drug testing in clinical practice: dispelling the myths and designing strategies. San Francisco, CA: California Academy of Family Physicians; 2006.
14. Cole BE. Recognizing and preventing medication diversion. Fam Pract Manag. 2001;8:37-41.
15. Jackman R, Purvis J, Mallett B. Chronic nonmalignant pain in primary care. Am Fam Physician. 2008;78:1155-1162.
16. Chou R, Fanciullo G, Fine P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113-130.
17. Chou R, Fanciullo G, Fine P, et al. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guideline. J Pain. 2009;10:131-146.
18. Moeller K, Lee K, Kissack J. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83:66-76.
19. Amabile C, Bowman B. Overview of oral modified-release opioid products for the management of chronic pain. Ann Pharmacotherapy. 2006;40:1327-1335. (Pubitemid 44204963)
20. Zhou S. Polymorphism of human cytochrome P450 2D6 and its clinical significance. Clin Pharmacokinet. 2009;48:689-723.
21. Drug Facts and Comparisons [online]. 2010. Available at: http://www.factsandcomparisons.com/. Accessed March 5, 2010.